nafamostat and ozagrel

nafamostat has been researched along with ozagrel in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (66.67)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inoue, M; Kato, H; Kondo, M; Sano, H; Sugino, S; Tanigawa, M; Yamamura, Y	1
Hamano, S; Inagaki, N; Koda, A; Nagai, H; Nakazawa, M; Ujiie, A; Yakuo, I	1
Kaminogo, M; Onizuka, M; Shibata, S; Yasunaga, A; Yonekura, M	1

Trials

1 trial(s) available for nafamostat and ozagrel

Article	Year
Combination of serine protease inhibitor FUT-175 and thromboxane synthetase inhibitor OKY-046 decreases cerebral vasospasm in patients with subarachnoid hemorrhage. Neurologia medico-chirurgica, 1998, Volume: 38, Issue:11 Topics: Aged; Aneurysm, Ruptured; Benzamidines; Brain Damage, Chronic; Brain Ischemia; Drug Evaluation; Drug Synergism; Enzyme Inhibitors; Female; Glasgow Coma Scale; Guanidines; Humans; Intracranial Aneurysm; Ischemic Attack, Transient; Male; Methacrylates; Middle Aged; Postoperative Complications; Rupture, Spontaneous; Serine Proteinase Inhibitors; Severity of Illness Index; Subarachnoid Hemorrhage; Thromboxane-A Synthase; Treatment Outcome	1998

Article

Year

Combination of serine protease inhibitor FUT-175 and thromboxane synthetase inhibitor OKY-046 decreases cerebral vasospasm in patients with subarachnoid hemorrhage.

Neurologia medico-chirurgica, 1998, Volume: 38, Issue:11

Topics: Aged; Aneurysm, Ruptured; Benzamidines; Brain Damage, Chronic; Brain Ischemia; Drug Evaluation; Drug Synergism; Enzyme Inhibitors; Female; Glasgow Coma Scale; Guanidines; Humans; Intracranial Aneurysm; Ischemic Attack, Transient; Male; Methacrylates; Middle Aged; Postoperative Complications; Rupture, Spontaneous; Serine Proteinase Inhibitors; Severity of Illness Index; Subarachnoid Hemorrhage; Thromboxane-A Synthase; Treatment Outcome

1998

Other Studies

2 other study(ies) available for nafamostat and ozagrel

Article	Year
Mechanism of polymorphonuclear leukocytes accumulation examined using inhibitors of complement and arachidonic acid cascade in rats treated with OK-432. Natural immunity and cell growth regulation, 1989, Volume: 8, Issue:5 Topics: Animals; Arachidonic Acids; Benzamidines; Benzoquinones; Biological Products; Cell Count; Chemotactic Factors; Complement C5a; Complement Inactivator Proteins; Edetic Acid; Egtazic Acid; Guanidines; Humans; Male; Methacrylates; Neutrophils; Peritoneal Cavity; Picibanil; Quinones; Rats; Rats, Inbred Strains; Sesquiterpenes	1989
Role of thromboxane (Tx) A2 in guinea pig Forssman shock and the effect of OKY-046, Tx A2 synthetase inhibitor. Prostaglandins, leukotrienes, and medicine, 1987, Volume: 26, Issue:2 Topics: Acrylates; Airway Resistance; Anaphylaxis; Animals; Benzamidines; Female; Forssman Antigen; Guanidines; Guinea Pigs; Male; Methacrylates; Thromboxane A2; Thromboxane-A Synthase	1987

Article

Year

Mechanism of polymorphonuclear leukocytes accumulation examined using inhibitors of complement and arachidonic acid cascade in rats treated with OK-432.

Natural immunity and cell growth regulation, 1989, Volume: 8, Issue:5

Topics: Animals; Arachidonic Acids; Benzamidines; Benzoquinones; Biological Products; Cell Count; Chemotactic Factors; Complement C5a; Complement Inactivator Proteins; Edetic Acid; Egtazic Acid; Guanidines; Humans; Male; Methacrylates; Neutrophils; Peritoneal Cavity; Picibanil; Quinones; Rats; Rats, Inbred Strains; Sesquiterpenes

1989

Role of thromboxane (Tx) A2 in guinea pig Forssman shock and the effect of OKY-046, Tx A2 synthetase inhibitor.

Prostaglandins, leukotrienes, and medicine, 1987, Volume: 26, Issue:2

Topics: Acrylates; Airway Resistance; Anaphylaxis; Animals; Benzamidines; Female; Forssman Antigen; Guanidines; Guinea Pigs; Male; Methacrylates; Thromboxane A2; Thromboxane-A Synthase

1987